MiraDx
MiraDx is a Los Angeles-based molecular genetics company that identifies, validates, develops, and delivers novel germline biomarker tests for individualized cancer treatment. Its goal is to improve human health and advance personalized medicine through the application of novel functional germline biomarkers.
Content by MiraDx
|3 min read
New Study Validates First and Only Molecular Diagnostic Test for Radiation Toxicity in Prostate Cancer
PROSTOX ultra is the first and only molecular diagnostic test to use biology and genetics to predict radiation toxicityPage 1 of 1
